 |
|
|
| |
An Open-Label Phase 1 Study to Evaluate Drug Interactions Between Multiple Weekly Doses of Ulonivirine (MK-8507) and Single Doses of Islatravir in Adults Without HIV
|
| |
| |
13th IAS Conference on HIV Science; Kigali, Rwanda, and online; July 13-17, 2025
Jesse Nussbaum*; Michelle Pham; Ryan Vargo; Yang Liu; Ilias Triantafyllou; Natasha Boyette; Randolph P. Matthews; S. Aubrey Stoch; Marian Iwamoto#; Gillian Gillespie
Merck & Co., Inc., Rahway, NJ, USA
*Presenting author
# An employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.,
Rahway, NJ, USA, at the time the study was conducted
|
| |
|
|
|
|
|
